Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Lucintel | PRODUCT CODE: 1418343

Cover Image

PUBLISHER: Lucintel | PRODUCT CODE: 1418343

Glucometer Market Report: Trends, Forecast and Competitive Analysis to 2030

PUBLISHED:
PAGES: 150 - page report
DELIVERY TIME: 3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4850
PDF (2 Users License)
USD 5800
PDF (5 Users License)
USD 6700
PDF (Corporate License)
USD 8850

Add to Cart

Glucometer Trends and Forecast

The future of the global glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets. The global glucometer market is expected to reach an estimated $30.5 billion by 2030 with a CAGR of 8.9% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.

A more than 150-page report is developed to help in your business decisions.

Glucometer by Segment

The study includes a forecast for the global glucometer by product, technique, type, distribution channel, and region.

Glucometer Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Continuous Glucose Monitoring Devices
  • Self-Monitoring Blood Glucose Systems

Glucometer Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

  • Invasive
  • Non-Invasive

Glucometer Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Wearable
  • Non-Wearable

Glucometer Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Institutional Sales
  • Hospitals
  • Clinics
  • Retail Sales
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Glucometer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Glucometer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies glucometer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glucometer companies profiled in this report include-

  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Glucometer Market Insights

Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.

Within this market, hospital pharmacies will remain the largest segment due to convenience to healthcare professionals.

North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.

Features of the Global Glucometer Market

Market Size Estimates: Glucometer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Glucometer market size by various segments, such as by product, technique, type, distribution channel, and region in terms of value ($B).

Regional Analysis: Glucometer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, technique, type, distribution channel, and regions for the glucometer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the glucometer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the glucometer market size?

Answer: The global glucometer market is expected to reach an estimated $30.5 billion by 2030.

Q2. What is the growth forecast for glucometer market?

Answer: The global glucometer market is expected to grow with a CAGR of 8.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the glucometer market?

Answer: The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.

Q4. What are the major segments for glucometer market?

Answer: The future of the glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets.

Q5. Who are the key glucometer market companies?

Answer: Some of the key glucometer companies are as follows.

  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Q6. Which glucometer market segment will be the largest in future?

Answer: Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.

Q7. In glucometer market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the glucometer market by product (continuous glucose monitoring devices and self-monitoring blood glucose systems), technique (invasive and non-invasive), type (wearable and non-wearable), distribution channel (institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Glucometer Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Glucometer Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Glucometer Market by Product
    • 3.3.1: Continuous Glucose Monitoring Devices
    • 3.3.2: Self-Monitoring Blood Glucose Systems
  • 3.4: Global Glucometer Market by Technique
    • 3.4.1: Invasive
    • 3.4.2: Non-Invasive
  • 3.5: Global Glucometer Market by Type
    • 3.5.1: Wearable
    • 3.5.2: Non-Wearable
  • 3.6: Global Glucometer Market by Distribution Channel
    • 3.6.1: Institutional Sales
    • 3.6.2: Hospitals
    • 3.6.3: Clinics
    • 3.6.4: Retail Sales
    • 3.6.5: Hospital Pharmacies
    • 3.6.6: Retail Pharmacies
    • 3.6.7: Online Pharmacies
    • 3.6.8: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Glucometer Market by Region
  • 4.2: North American Glucometer Market
    • 4.2.2: North American Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.2.3: North American Glucometer Market by Type: Wearable and Non-Wearable
    • 4.2.4: North American Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
  • 4.3: European Glucometer Market
    • 4.3.1: European Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
    • 4.3.2: European Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.3.3: European Glucometer Market by Type: Wearable and Non-Wearable
    • 4.3.4: European Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
  • 4.4: APAC Glucometer Market
    • 4.4.1: APAC Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
    • 4.4.2: APAC Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.4.3: APAC Glucometer Market by Type: Wearable and Non-Wearable
    • 4.4.4: APAC Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
  • 4.5: ROW Glucometer Market
    • 4.5.1: ROW Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
    • 4.5.2: ROW Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.5.3: ROW Glucometer Market by Type: Wearable and Non-Wearable
    • 4.5.4: ROW Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Glucometer Market by Product
    • 6.1.2: Growth Opportunities for the Global Glucometer Market by Technique
    • 6.1.3: Growth Opportunities for the Global Glucometer Market by Type
    • 6.1.4: Growth Opportunities for the Global Glucometer Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Glucometer Market by Region
  • 6.2: Emerging Trends in the Global Glucometer Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Glucometer Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glucometer Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Promega Corporation
  • 7.3: Agilent Technologies
  • 7.4: Bio-Rad Laboratories
  • 7.5: QIAGEN
  • 7.6: Merck
  • 7.7: B.D.
  • 7.8: Sanofi
  • 7.9: Ascensia Diabetes Care Holdings
  • 7.10: Abbott
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!